Totaligent Announces Formation of Joint Venture with GloMed Solutions to Commercialize Advanced Biologics in Japan and APAC

BOCA RATON, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- Totaligent, Inc. (OTCID: TGNT) (“Totaligent” or “the Company”), today announced the formation of a 50/50 joint venture between its wholly owned subsidiary, Aetherium Medical LLC, and GloMed Solutions Limited Liability Company (“GloMed”), a Japanese company with a proven distribution network in the Asia-Pacific region.